Some encouraging results from a trial of Maraviroc (or Selzentry) to reduce the risk of Graft vs Host Disease following allogeneic stem cell transplants, particularly with respect to liver and gut-related GvHD. 32 more words
Tags » Chronic GVHD
Sorry for the delay in an update as to how David is doing. Thank you for your patience.
As some of you may know I went to Germany (where my brother lives) and Ireland for about 12 days. 1,099 more words
Yes, you are reading correctly and maybe making the assumption that David is back in the hospital….and you would be right. But, we are hoping this time it is only for one night. 252 more words